Sliwiński P
Kliniki Chorób Płuc Instytutu Gruźlicy i Chorób Płuc, Warszawie.
Pneumonol Alergol Pol. 1992;60(9-10):13-9.
Long-term oxygen therapy (LTOT) became a routine in the treatment of severe respiratory failure and cor pulmonale. Four years experience of the LTOT in Warsaw is presented. From 237 patients referred 172 were qualified for treatment. Majority--130 (76%) suffered from COPD. The rest of the group presented with pulmonary fibrosis, tb sequelae, bronchiectasis, kyphoscoliosis or chronic pulmonary thromboembolic disease. The mean oxygen breathing time averaged 14.5 H/day. Seventy two patients that is 42% of treated group died. The most frequent (63%) cause of death was respiratory failure. No adverse effects of LTOT were observed.
长期氧疗（LTOT）已成为治疗严重呼吸衰竭和肺心病的常规疗法。本文介绍了在华沙开展长期氧疗的四年经验。在转诊的237例患者中，172例符合治疗条件。其中大多数——130例（76%）患有慢性阻塞性肺疾病（COPD）。其余患者患有肺纤维化、肺结核后遗症、支气管扩张、脊柱后凸侧弯或慢性肺血栓栓塞症。平均每日吸氧时间为14.5小时。72例患者（占治疗组的42%）死亡。最常见的（63%）死亡原因是呼吸衰竭。未观察到长期氧疗的不良反应。
